Alexander A. Fitzpatrick - 28 Sep 2023 Form 4 Insider Report for ARS Pharmaceuticals, Inc. (SPRY)

Role
Chief Legal Officer
Signature
/s/ Alexander Fitzpatrick
Issuer symbol
SPRY
Transactions as of
28 Sep 2023
Transactions value $
$319,954
Form type
4
Filing time
02 Oct 2023, 16:23:09 UTC
Previous filing
05 Jan 2023
Next filing
04 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRY Common Stock Purchase $145K +40K +1347.25% $3.62 43K 28 Sep 2023 Direct F1, F2
transaction SPRY Common Stock Purchase $175K +46.3K +107.65% $3.78 89.2K 29 Sep 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is the weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.60 to $3.64, inclusive. Upon request by the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
F2 Includes 2,969 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on June 30, 2023.
F3 The price reported in Column 4 is the weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.70 to $3.85, inclusive. Upon request by the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.